Anzeige
Mehr »
Samstag, 25.07.2026 - Börsentäglich über 12.000 News
Tiefseebergbau erfordert echte Offshore-Expertise
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 881351 | ISIN: US68554V1089 | Ticker-Symbol: EP3
Tradegate
24.07.26 | 13:37
3,560 Euro
+1,71 % +0,060
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ORASURE TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
ORASURE TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,4803,50013:04
3,4403,54024.07.

Aktuelle News zur ORASURE TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiOraSure Technologies, Inc.: OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th1
MiOraSure wins FDA emergency use nod for new Ebola test1
DiOraSure Technologies, Inc.: OraSure Receives Emergency Use Authorization for Second Generation Ebola Test166BETHLEHEM, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced...
► Artikel lesen
11.06.ORASURE TECHNOLOGIES INC - 8-K, Current Report2
ORASURE TECHNOLOGIES Aktie jetzt für 0€ handeln
11.06.OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient-Friendly Access to Testing for Sexually Transmitted Infections226BETHLEHEM, Pa., June 11, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OraSure") (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions today announced...
► Artikel lesen
03.06.ORASURE TECHNOLOGIES INC - 8-K, Current Report1
08.05.ORASURE TECHNOLOGIES INC - 10-Q, Quarterly Report-
07.05.OraSure anticipates Q2 revenue of $27M-$30M as it targets midyear FDA clearances for CT/NG and Colli-Pee1
22.04.OraSure Technologies, Inc.: OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th1
17.04.OraSure gains after cooperation pact with activist, adds nominee to board17
17.04.ORASURE TECHNOLOGIES INC - 8-K, Current Report-
17.04.OraSure appoints John Bertrand to board, settles with Altai2
17.04.OraSure Technologies, Inc.: OraSure Technologies Appoints John D. Bertrand to its Board of Directors1
30.03.ORASURE TECHNOLOGIES INC - 8-K, Current Report-
18.03.Altai Capital Presses OraSure Board For Overhaul, Nominates Two Directors2
17.03.OraSure Technologies, Inc.: OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital1
17.03.Activist Altai Capital pushes for OraSure sale, board seats6
17.03.Altai Capital pushes for board seats at OraSure Technologies1
09.03.ORASURE TECHNOLOGIES INC - 10-K, Annual Report2
05.03.ORASURE TECHNOLOGIES INC - 8-K, Current Report1
Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1